American Glaucoma Society (AGS)
Feb 27 - Mar 1, 2020
A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG)
Supporting Materials
Location
Washington, DC